Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

15 January 2004 : Original article  

Human Omentum Majus as A Potential Source of Osteogenic Cells for Tissue Engineering (preliminary report)

P Kowalczyk, R M Olkowski, E Sienkiewicz-Latka, W Lisik, M Sinski, M Kosieradzki, Z Wierzbicki, J Przybylski, M Lewandowska-Szumiel

Ann Transplant 2004; 9(1A): 61-63 :: ID: 15636


For the skeletal tissue engineering autologous stem cells are obtained from the bone marrow (BM). However, BM procurement procedures may be painful and may yield low number of stem cells upon processing. There is a need for other convenient stem cells sources.
The omentum majus is potential source of mesenchymal tissues. Thus the aim of this study was to determine if stem cells potentially present in human omentum majus could differentiate into osteogenic tissue. The observations were also performed in the presence of chosen biomaterials (steel, titanium, alumina, hydroxyapatite).
Collected cells were incubated on 96 wells plate (15000 cells per well) per one week in control media (i.e. DMEM + 10% FBS) without vitamin C and with vitamin C, and media enriched with: vitamin D3, dexamethasone. Human osteoblasts were used as a control. Osteocalcin level and alkaline phosphatase activity were compared between groups. Our results suggest that in humans, the omentum majus adipose tissue is able to respond to vitamin C, vitamin D3 and dexamethasone in a manner similar to osteoblasts. The results were confirmed on several chosen biomaterials. It suggests that these cells may express an osteoblast-like phenotype. Thus omentum may be taken into account as potential source of stem cells for skeletal reconstruction.

Keywords: Tissue Engineering, Mesenchymal Stem Cells, Omentum Majus, Cell Differentiation, Osteoblasts


In Press

04 Aug 2022 : Original article  

Long-Term Patency of All-in-One Sleeve Patch Graft Venoplasty in 16 Patients Who Underwent Living Donor Liv...

Ann Transplant In Press; DOI: 10.12659/AOT.936888  

22 Jul 2022 : Original article  

Diagnostic Role of Tumor Markers for Hepatocellular Carcinoma in Liver Transplantation Candidates: An Analy...

Ann Transplant In Press; DOI: 10.12659/AOT.936937  

22 Jul 2022 : Original article  

Development of a Novel Model for Predicting Postoperative Short-Term Outcome in Patients with Hepatitis B-R...

Ann Transplant In Press; DOI: 10.12659/AOT.936732  

22 Jul 2022 : Original article  

Leucine-Rich Alpha-2-Glycoprotein (LRG-1) as a Potential Kidney Injury Marker in Kidney Transplant Recipients

Ann Transplant In Press; DOI: 10.12659/AOT.936751  

Most Viewed Current Articles

26 Jan 2022 : Review article  

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models

DOI :10.12659/AOT.934924

Ann Transplant 2022; 27:e934924

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

24 Jul 2020 : Review article  

Kidney Transplantation in the Times of COVID-19 – A Literature Review

DOI :10.12659/AOT.925755

Ann Transplant 2020; 25:e925755

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358